2022 Top 500 ranking: 85
In early February, with financial markets oblivious to medical experts’ warnings about the dangers posed by the coronavirus, Ian Pizer of Aviva Investors’ investment strategy team began to look into the medical research to learn more about the potential outcomes and the implications for the global economy and markets. What ...
Aviva
You are not logged in, Sign in or register to request access.
Please note: If you had prior access to this content you may need to sign in again.
Non-asset management investment service providers are able to purchase a subscription for access to premium content such as:
Get access to premium content subscribe today